SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-017213
Filing Date
2011-02-23
Accepted
2011-02-23 17:19:08
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y04571e10vk.htm 10-K 1491801
2 EX-23.1 y04571exv23w1.htm EX-23.1 1908
3 EX-31.1 y04571exv31w1.htm EX-31.1 8333
4 EX-31.2 y04571exv31w2.htm EX-31.2 8321
5 EX-32.1 y04571exv32w1.htm EX-32.1 3144
6 EX-32.2 y04571exv32w2.htm EX-32.2 3151
7 GRAPHIC y04571y0457101.gif GRAPHIC 15307
8 GRAPHIC y04571y0457102.gif GRAPHIC 18283
9 GRAPHIC y04571y0457103.gif GRAPHIC 19764
10 GRAPHIC y04571y0457104.gif GRAPHIC 15733
11 GRAPHIC y04571y0457105.gif GRAPHIC 6115
12 GRAPHIC y04571y0457100.gif GRAPHIC 1595
  Complete submission text file 0000950123-11-017213.txt   1625043
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 11633114
SIC: 2836 Biological Products, (No Diagnostic Substances)